iodohippurate sodium i-123 (nephroflow) Report issue

Active Ingredient History

  • Now
I-123 radiolabeled ortho-iodohippurate is commonly employed for evaluating effective renal plasma flow (ERPF) by means of either in vivo scintigraphy and/or plasma clearance curves. It has been used to evaluate renal functioning in patients with obstructive uropathy, vesicorenal reflux, hypertensiion due to renal artery stenosis.   NCATS

  • SMILES: OC(=O)CNC(=O)C1=CC=CC=C1[123I]
  • Mol. Mass: 301.0703
  • ALogP: 1.11
  • ChEMBL Molecule:
More Chemistry
  • Mechanisms of Action: Missing data
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Parenteral
  • Pro Drug: No
iodohippurate sodium i 123 | iodohippurate sodium i-123 | nephroflow | sodium iodohippurate (123i) | sodium o-iodo-(123i)-hippurate


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue